Identification of an Evolutionarily Conserved Domain in Human Lens Epithelium-derived Growth Factor/Transcriptional Co-activator p75 (LEDGF/p75) That Binds HIV-1 Integrase
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Human lens epithelium-derived growth factor/transcriptional co-activator p75 (LEDGF/p75) protein was recently identified as a binding partner for HIV-1 integrase (IN) in human cells. In this work, we used biochemical and bioinformatic approaches to define the domain organization of LEDGF/p75. Using limited proteolysis and deletion mutagenesis we show that the protein contains a pair of evolutionarily conserved domains, assuming about 35% of its sequence. Whereas the N-terminal PWWP domain had been recognized previously, the second domain is novel. It is comprised of approximately 80 amino acid residues and is both necessary and sufficient for binding to HIV-1 IN. Strikingly, the integrase binding domain (IBD) is not unique to LEDGF/p75, as a second human protein, hepatoma-derived growth factor-related protein 2 (HRP2), contains a homologous sequence. LEDGF/p75 and HRP2 IBDs avidly bound HIV-1 IN in an in vitro GST pull-down assay and each full-length protein potently stimulated HIV-1 IN activity in vitro. LEDGF/p75 and HRP2 are predicted to share a similar domain organization and have an evident evolutionary and likely functional relationship.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“LEDGF/p75 appears to function as a bimodal tether in lentiviral integration targeting.”
From Structure and function of retroviral integrase (2022) · cites this paper as [105]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Elements including a PWWP chromatin reader domain and two copies of an AT-hook DNA binding motif in the N-terminal half of the protein mediate its association with chromatin, while the C-terminal IN-binding domain (IBD) confers binding to IN103–105.”
From Structure and function of retroviral integrase (2022) · cites this paper as [105]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels
Shevchenko, A., Wilm, M., Vorm, O., & Mann, M. (1996) · Analytical Chemistry · doi:10.1021/ac950914h · Cited by 8,995
Amino acid substitution matrices from protein blocks.
Henikoff, S., & Henikoff, J. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10915 · Cited by 6,218
LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., et al. (2003) · Science · doi:10.1126/science.1088547 · Cited by 3,587
ESPript: analysis of multiple sequence alignments in PostScript.
Gouet, P., Courcelle, E., Stuart, D. I., & M√©toz, F. (1999) · Bioinformatics · doi:10.1093/bioinformatics/15.4.305 · Cited by 2,951
InterProScan – an integration platform for the signature-recognition methods in InterPro
Zdobnov, E. M., & Apweiler, R. (2001) · Bioinformatics · doi:10.1093/bioinformatics/17.9.847 · Cited by 2,939
HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots
Schröder, A. R. W., Shinn, P., Chen, H., Berry, C., Ecker, J. R., & Bushman, F. (2002) · Cell · doi:10.1016/s0092-8674(02)00864-4 · Cited by 1,832
Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration
Wu, X., Li, Y., Crise, B., & Burgess, S. M. (2003) · Science · doi:10.1126/science.1083413 · Cited by 1,305
Inhibitors of Strand Transfer That Prevent Integration and Inhibit HIV-1 Replication in Cells
Hazuda, D. J., Felock, P., Witmer, M., Wolfe, A., Stillmock, K., Grobler, J. A., Espeseth, A., Gabryelski, L., Schleif, W., Blau, C., et al. (2000) · Science · doi:10.1126/science.287.5453.646 · Cited by 1,131
SMART 4.0: towards genomic data integration
Letunic, I. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh088 · Cited by 1,003
Exhaustive Matching of the Entire Protein Sequence Database
Gonnet, G. H., Cohen, M. A., & Benner, S. A. (1992) · Science · doi:10.1126/science.1604319 · Cited by 840
Research works printed but not linked: 4
- Engelman, 2003, Curr. Top. Microbiol. Immunol., 281, 209
- Cowan, 1990, Pept. Res., 3, 75
- Bram, 1993, Mol. Cell. Biol., 13, 4760
- Cherepanov, 2000, FASEB J., 14, 1389
Cited by
Items 101–200 of 296
An Allosteric Mechanism for Inhibiting HIV-1 Integrase with a Small Molecule
Kessl, J. J., Eidahl, J. O., Shkriabai, N., Zhao, Z., McKee, C. J., Hess, S., Burke, T. R., & Kvaratskhelia, M. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.058883 · Cited by 50
“LEDGF directly interacts with IN through a Cterminal region termed the integrase binding domain (IBD) (Cherepanov et al., 2004; Vanegas et al., 2005) and tethers the preintegration complex to chromatin (Maertens et al.”
BackgroundHepatoma-derived growth factor-related protein 2 promotes DNA repair by homologous recombination
Baude, A., Aaes, T. L., Zhai, B., Al-Nakouzi, N., Oo, H. Z., Daugaard, M., Rohde, M., & Jäättelä, M. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1526 · Cited by 56
“It is implicated in various nuclear processes such as epigenetic regulation (8,9), chromatin structure modulation (10,11) and DNA repair (12,13).”
BackgroundYeast two-hybrid detection of integrase–host factor interactions
Rain, J., Cribier, A., Gérard, A., Emiliani, S., & Bénarous, R. (2009) · Methods · doi:10.1016/j.ymeth.2009.02.002 · Cited by 58
Serrao, E., Xu, Z.-L., Debnath, B., Christ, F., Debyser, Z., Long, Y.-Q., & Neamati, N. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.07.047 · Cited by 47
Chen, P., & Li, J. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-402 · Cited by 51
“Previous results showed that the IBD is both necessary and sufficient for the interaction with HIV-1 IN [51,52].”
HIV-1 Integrase Multimerization as a Therapeutic Target
Feng, L., Larue, R. C., Slaughter, A., Kessl, J. J., & Kvaratskhelia, M. (2015) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2015_439 · Cited by 45
“Mutagenesis studies have mapped the principal interacting interfaces between the C-terminal fragment of LEDGF/p75, termed the integrase-binding domain (IBD), and the IN CCD and NTD domains (Cherepanov et al. 2004, 2005b).”
BackgroundTsiang, M., Jones, G. S., Hung, M., Mukund, S., Han, B., Liu, X., Babaoglu, K., Lansdon, E., Chen, X., Todd, J., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.040121 · Cited by 45
Going beyond Integration: The Emerging Role of HIV-1 Integrase in Virion Morphogenesis
Elliott, J. L., & Kutluay, S. B. (2020) · Viruses · doi:10.3390/v12091005 · Cited by 51
Gijsbers, R., Vets, S., De Rijck, J., Ocwieja, K. E., Ronen, K., Malani, N., Bushman, F. D., & Debyser, Z. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.255711 · Cited by 44
RetractedZielske, S. P., & Stevenson, M. (2006) · Journal of Virology · doi:10.1128/jvi.02470-05 · Cited by 43
“(2) that a motif present in the integration binding domain of LEDGFp75 is also present in other proteins.”
Factors that mold the nuclear landscape of HIV-1 integration
Bedwell, G. J., & Engelman, A. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1207 · Cited by 44
“LEDGF/p75 is a member of the hepatoma-derived growth factor (HDGF) family, of which one other member, HDGF like protein 2 (HDGFL2), contains an IBD that is homologous to the LEDGF/p75 IBD (128,144).”
BackgroundInfluentialSelf-citationMurai, M. J., Pollock, J., He, S., Miao, H., Purohit, T., Yokom, A., Hess, J. L., Muntean, A. G., Grembecka, J., & Cierpicki, T. (2014) · Blood · doi:10.1182/blood-2014-01-550079 · Cited by 41
“The catalytic domain of HIV-IN binds to the C-terminal integrase-binding domain (IBD) of LEDGF,(11) and multiple studies validated this protein-protein interaction as necessary for HIV-1 replication.(9,11,12) Targeting the IBDIN interaction attracted strong attention as a valuable approach to develop novel antiretrovi…”
BackgroundBrown‐Bryan, T. A., Leoh, L. S., Ganapathy, V., Pacheco, F. J., Mediavilla-Varela, M., Filippova, M., Linkhart, T. A., Gijsbers, R., Debyser, Z., & Casiano, C. A. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0125 · Cited by 49
“binding domain and the autoepitope recognized by human antiLEDGF/p75 autoantibodies (30, 43-45).”
BackgroundWielens, J., Headey, S. J., Jeevarajah, D., Rhodes, D. I., Deadman, J. J., Chalmers, D. K., Scanlon, M. J., & Parker, M. W. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.03.016 · Cited by 46
“The best described IN–protein interaction for IN is with the human cellular protein, LEDGF [25,29,36–41] which has been characterized biochemically and by X-ray crystallography.”
BackgroundMultimodal mechanism of action of allosteric HIV-1 integrase inhibitors
Jurado, K. A., & Engelman, A. (2013) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2013.15 · Cited by 40
Self-citationNuclear protein LEDGF/p75 recognizes supercoiled DNA by a novel DNA-binding domain
Tsutsui, K., Sano, K., Hosoya, O., Miyamoto, T., & Tsutsui, K. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr088 · Cited by 46
Debyser, Z., Vansant, G., Bruggemans, A., Janssens, J., & Christ, F. (2018) · Viruses · doi:10.3390/v11010012 · Cited by 46
“The only structured domain within this region is the integrase binding domain (IBD), named for its interaction with HIV integrase (IN) [62], although later work has demonstrated that many other cellular interaction partners also bind LEDGF/p75 through this domain [63].”
BackgroundPeptides that inhibit HIV‐1 integrase by blocking its protein–protein interactions
Maes, M., Loyter, A., & Friedler, A. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08680.x · Cited by 145
Affinity switching of the LEDGF/p75 IBD interactome is governed by kinase-dependent phosphorylation
Sharma, S., Čermáková, K., Rijck, J. D., Demeulemeester, J., Fábry, M., Ashkar, S. E., Belle, S. V., Lepšík, M., Těšina, P., Duchoslav, V., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1803909115 · Cited by 43
“This domain is commonly referred to as the integrase binding domain (IBD) because HIV integrase was the first identified binding partner of this domain (5).”
BackgroundTraditional Chinese medicine application in HIV: anin silicostudy
Huang, H.-J., Jian, Y.-R., & Chen, C. Y. (2012) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2012.745168 · Cited by 38
Maertens, G. N., Vercammen, J., Debyser, Z., & Engelborghs, Y. (2005) · The FASEB Journal · doi:10.1096/fj.04-3373fje · Cited by 48
HIV-1 Integrase: From Biology to Chemotherapeutics
Loizidou, E. Z., Nicolaou, C. A., Nicolaides, A. V., & Kostrikis, L. G. (2007) · Current HIV Research · doi:10.2174/157016207781023965 · Cited by 43
“Grey NTD (corresponds to residues 1 to 325), contains a PWWP motif (residues 1 to 91) and a NLS domain (residues 148-156), Pink CTD (residues 325 to 530), contains the IBD domain (purple, residues 347-429) [40].”
BackgroundMeehan, A. M., Saenz, D. T., Morrison, J. H., Hu, C., Peretz, M., & Poeschla, E. M. (2011) · Journal of Virology · doi:10.1128/jvi.01295-10 · Cited by 38
Inhibitors of the Interactions between HIV‐1 IN and the Cofactor LEDGF/p75
Luca, L. D., Ferro, S., Morreale, F. E., Grazia, S. D., & Chimirri, A. (2011) · ChemMedChem · doi:10.1002/cmdc.201100071 · Cited by 36
Zhang, D., Yan, H.-L., Xu, X., Xu, L., Yin, Z., Chang, S., & Luo, H. (2020) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2020.1743282 · Cited by 37
GS-9822, a Preclinical LEDGIN Candidate, Displays a Block-and-Lock Phenotype in Cell Culture
Bruggemans, A., Vansant, G., Balakrishnan, M., Mitchell, M. L., Cai, R., Christ, F., & Debyser, Z. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02328-20 · Cited by 35
Strategies for Targeting Retroviral Integration for Safer Gene Therapy: Advances and Challenges
Yoder, K. E., Rabe, A. J., Fishel, R. A., & Larue, R. C. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.662331 · Cited by 41
Basu, A., Woods‐Burnham, L., Ortiz, G., Ríos-Colón, L., Figueroa, J. D., Albesa, R., Andrade, L. E. C., Mähler, M., & Casiano, C. A. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.07.014 · Cited by 36
“Our group demonstrated previously that the extreme N-terminal (residues 1-85) and Cterminal domains of DFS70/LEDGFp75 (residues 485-530) are removed by caspases during apoptosis, generating truncated proteins with altered function that still contain an intact autoepitope/IBD region [54].”
BackgroundInfluentialBueno, M. T. D., Garcia-Rivera, J. A., Kugelman, J. R., Morales, E., Rosas-Acosta, G., & Llano, M. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.03.063 · Cited by 39
“14,15 In addition, deletion of the IBD domain is known to abolish this interaction.(12,39) Plasmids encoding LEDGF/p75 WT or LEDGF/p75 ΔIBD were transiently transfected”
BackgroundMechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361–370
Hayouka, Z., Levin, A., Maes, M., Hadas, E., Shalev, D. E., Volsky, D. J., Loyter, A., & Friedler, A. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.100 · Cited by 38
“HRP2 also has a functional IBD [4,6] similar to LEDGF.”
BackgroundInfluentialCellular Cofactors of Lentiviral Integrase: From Target Validation to Drug Discovery
Taltynov, O., Desimmie, B. A., Demeulemeester, J., Christ, F., & Debyser, Z. (2012) · Molecular Biology International · doi:10.1155/2012/863405 · Cited by 37
“Soon an evolutionary highly conserved protein-binding domain spanning amino acids 347–429 was identified by means of limited proteolysis and deletion mutagenesis [77].”
BackgroundIn search of small molecules blocking interactions between HIV proteins and intracellularcofactors
Busschots, K., Rijck, J. D., Christ, F., & Debyser, Z. (2008) · Molecular BioSystems · doi:10.1039/b810306b · Cited by 39
Virological and Cellular Roles of the Transcriptional Coactivator LEDGF/p75
Llano, M., Morrison, J. H., & Poeschla, E. M. (2009) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-02175-6_7 · Cited by 42
“This C-terminal portion of LEDGF/p75 contains the IN binding domain (IBD, residues 340–417) which is central to the protein’s virological and cellular significance [14, 93].”
BackgroundMethodRhodes, D. I., Peat, T. S., Vandegraaff, N., Jeevarajah, D., Newman, J. M., Martyn, J. C., Coates, J. A. V., Ede, N. J., Rea, P., & Deadman, J. J. (2011) · ChemBioChem · doi:10.1002/cbic.201100350 · Cited by 37
In Vitro DNA Tethering of HIV-1 Integrase by the Transcriptional Coactivator LEDGF/p75
McNeely, M., Hendrix, J., Busschots, K., Boons, E., Deleersnijder, A., Gérard, M., Christ, F., & Debyser, Z. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.03.073 · Cited by 39
Synthesis and Evaluation of Aryl Quinolines as HIV-1 Integrase Multimerization Inhibitors
Jentsch, N. G., Hart, A. P., Hume, J. D., Sun, J., McNeely, K. A., Lama, C., Pigza, J. A., Donahue, M. G., & Kessl, J. J. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00269 · Cited by 32
Janssens, J., De Wit, F., Parveen, N., & Debyser, Z. (2022) · mBio · doi:10.1128/mbio.00007-22 · Cited by 28
Kim, G.-H., Yang, J., Jeon, D., Kim, J., Chae, G. Y., Jang, M., & Lee, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124384 · Cited by 36
Anti-HIV Drug Development Through Computational Methods
Gu, W.-G., Zhang, X., & Yuan, J. F. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9604-9 · Cited by 36
“Lens epithelium-derived growth factor (LEDGF/ p75) is the first reported cellular factor to interact with integrase (28, 29).”
BackgroundProtein–protein and protein–chromatin interactions of LEDGF/p75 as novel drug targets
Blokken, J., Rijck, J. D., Christ, F., & Debyser, Z. (2017) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2017.11.002 · Cited by 34
Expression of Hepatoma-derived growth factor family members in the adult central nervous system
Eltahir, H. M., Dietz, F., Dringen, R., Schwabe, K., Strenge, K. S., Kelm, S., Abouzied, M. M., Gieselmann, V., & Franken, S. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-6 · Cited by 35
“The latter activity has also been shown for HRP-2 [18].”
BackgroundNaughtin, M., Haftek-Terreau, Z., Xavier, J., Meyer, S., Silvain, M., Jaszczyszyn, Y., Levy, N., Miele, V., Benleulmi, M. S., Ruff, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129427 · Cited by 37
Kumar, D., Sharma, P., Shabu, Kaur, R., Lobe, M. M. M., Gupta, G. K., & Ntie‐Kang, F. (2021) · RSC Advances · doi:10.1039/d0ra10655k · Cited by 28
Sites of retroviral DNA integration: From basic research to clinical applications
Serrao, E., & Engelman, A. (2015) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2015.1102859 · Cited by 36
“The C-terminal side of the tether contains the IN-binding domain (IBD), which is necessary and sufficient to bind HIV-1 IN in vitro (Cherepanov et al., 2004).”
BackgroundInfluentialSelf-citationZhao, Y., Li, W., Zeng, J., Liu, G., & Tang, Y. (2008) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21955 · Cited by 29
Voet, A. R. D., & Zhang, K. Y. J. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802651616 · Cited by 32
Sapp, N., Burge, N. L., Cox, K. L., Thapa, S., Prakash, P., Balasubramaniam, M., Christensen, D. E., Li, M., Linderberger, J., Kvaratskhelia, M., et al. (2022) · Journal of Virology · doi:10.1128/jvi.01011-22 · Cited by 34
“This LEDGF/p75 binding to the nucleosome requires the DNA-binding domains, PWWP and AT-hooks, since a LEDGF/p75 mutant containing only the integrasebinding domain (IBD) failed to bind the nucleosome (see Fig.”
BackgroundBrady, T., Kelly, B. J., Male, F., Roth, S. L., Bailey, A., Malani, N., Gijsbers, R., O’Doherty, U., & Bushman, F. D. (2013) · Journal of Virological Methods · doi:10.1016/j.jviromet.2013.01.004 · Cited by 34
“These ncluded the LEDGF/p75 C-terminal region fused to CBX1, a verion of this chimera defective for integrase binding (the D366N utation; Cherepanov et al., 2004; Llano et al., 2006), and an intact ersion of LEDGF/p75 expressed from a modified gene engineered o be insensitive to the siRNAs used for knock down.”
Early stages of HIV replication: how to hijack cellular functions for a successful infection.
Lehmann‐Che, J., & Saïb, A. (2004) · PubMed · Cited by 48
Strategies to inhibit viral protein nuclear import: HIV-1 as a target
Levin, A., Loyter, A., & Bukrinsky, M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.07.010 · Cited by 34
“The cellular protein LEDGF/p75, a binding partner of IN, interacts with IN primarily through a domain termed the Integrase Binding Domain (IBD) [19].”
BackgroundLocalization and functions of native and eGFP-tagged capsid proteins in HIV-1 particles
Francis, A. C., Cereseto, A., Singh, P. K., Shi, J., Poeschla, E. M., Engelman, A., Aiken, C., & Melikyan, G. B. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010754 · Cited by 22
Self-citationStructural Properties of HIV Integrase·Lens Epithelium-derived Growth Factor Oligomers
Gupta, K., Diamond, T., Hwang, Y., Bushman, F., & Van Duyne, G. D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.114413 · Cited by 24
TOX4 and NOVA1 Proteins Are Partners of the LEDGF PWWP Domain and Affect HIV-1 Replication
Morchikh, M., Naughtin, M., Nunzio, F. D., Xavier, J., Charneau, P., Jacob, Y., & Lavigne, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081217 · Cited by 29
“GST pull down were performed as described in [32] and adapted in [15].”
BackgroundMethodLi, X., Koh, Y., & Engelman, A. (2012) · Journal of Virology · doi:10.1128/jvi.06386-11 · Cited by 24
Self-citationAl‐Mawsawi, L. Q., Hombrouck, A., Dayam, R., Debyser, Z., & Neamati, N. (2008) · Virology · doi:10.1016/j.virol.2008.04.030 · Cited by 24
van Bel, N., van der Velden, Y., Bonnard, D., Le Rouzic, E., Das, A. T., Benarous, R., & Berkhout, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103552 · Cited by 23
“LEDGF/p75 binds chromatin via the N-terminal domain [5] and the C-terminal IN binding domain (IBD) recognizes the cleft formed at the IN dimeric interface [6,7].”
BackgroundThe Interaction Between Lentiviral Integrase and LEDGF: Structural and Functional Insights
Hare, S., & Cherepanov, P. (2009) · Viruses · doi:10.3390/v1030780 · Cited by 28
“However, it is important to note that the affinity of HIV-1 IN for HRP2 is markedly lower than it is for LEDGF [43]; it is currently unclear whether HRP2 has any function in lentiviral replication.”
BackgroundSelf-citationChromatin tethering and retroviral integration: Recent discoveries and parallels with DNA viruses
Meehan, A. M., & Poeschla, E. M. (2009) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2009.10.001 · Cited by 27
“HIV-1 lentivirus LEDGF/p75 AT hooks bind AT rich DNA, PWWP ligand unknown IN [7, 10, 12, 35, 44, 89]”
BackgroundInfluentialImpact of Chromatin on HIV Replication
Agosto, L. M., Gagné, M., & Henderson, A. J. (2015) · Genes · doi:10.3390/genes6040957 · Cited by 24
Garcia-Rivera, J. A., Bueno, M. T. D., Morales, E., Kugelman, J. R., Rodríguez, D. F., & Llano, M. (2009) · Journal of Virology · doi:10.1128/jvi.01043-09 · Cited by 33
“Although analyses of LEDGF/p75 deletion mutants were used previously to successfully map functional domains in LEDGF/p75 (8, 22, 23, 39, 41), this approach could lead to misinterpretations due to the global impact of mutations on the structure and, hence, the function of the analyzed protein.”
BackgroundMethodAnti-HIV-1 Therapeutics: From FDA-approved Drugs to Hypothetical Future Targets
Adamson, C. S., & Freed, E. O. (2009) · Molecular Interventions · doi:10.1124/mi.9.2.5 · Cited by 24
“LEDGF contains a C-terminal IN-binding domain and an N-terminal sequence that interacts with chromatin (11, 12).”
BackgroundTsiang, M., Jones, G. S., Hung, M., Samuel, D., Novikov, N. Y., Mukund, S., Brendza, K. M., Niedziela‐Majka, A., Jin, D., Liu, X., et al. (2011) · Biochemistry · doi:10.1021/bi101504w · Cited by 22
HIV-1 IN/Pol recruits LEDGF/p75 into viral particles
Desimmie, B. A., Weydert, C., Schrijvers, R., Vets, S., Demeulemeester, J., Proost, P., Paron, I., Rijck, J. D., Mast, J., Bannert, N., et al. (2015) · Retrovirology · doi:10.1186/s12977-014-0134-4 · Cited by 21
“Whereas the N-terminal PWWP domain of LEDGF/p75 reads chromatin modifications [11-13], the C-terminal integrase binding domain (IBD) interacts with lentiviral IN [14]; together they direct”
Retroviral integrase protein and intasome nucleoprotein complex structures
Grawenhoff, J., & Engelman, A. (2017) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v8.i1.32 · Cited by 26
Self-citationMultivalent interactions essential for lentiviral integrase function
Ballandras-Colas, A., Chivukula, V., Gruszka, D. T., Shan, Z., Singh, P. K., Pye, V. E., McLean, R. K., Bedwell, G. J., Li, W., Nans, A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29928-8 · Cited by 25
“Blots probed with anti-LEDGF/p75, anti-HRP2, and anti-capsid/p24 antibodies were developed following incubation with horseradish peroxidase-conjugated goat anti-rabbit IgG antibody (BioRad; product code 1706515) or IRDye 800CW conjugated goat anti-rabbit IgG antibody (LI-COR; product code 925-32211) for detection by c…”
BackgroundMethodInfluentialSelf-citationCrucitti, G. C., Pescatori, L., Messore, A., Madia, V. N., Pupo, G., Saccoliti, F., Scipione, L., Tortorella, S., Leva, F. S. D., Cosconati, S., et al. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.06.036 · Cited by 19
Pleiotropic Nature of HIV‐1 Integrase Mutations
Engelman, A. (2011) · HIV‐1 Integrase · doi:10.1002/9781118015377.ch6 · Cited by 20
Self-citationComplex Relationships between HIV-1 Integrase and Its Cellular Partners
Rozina, A., Anisenko, A. N., Kikhai, T. F., Silkina, M. O., & Gottikh, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012341 · Cited by 23
“LEDGF/p75 includes a C-terminus IBD domain (IN-binding domain) and a conservative N-terminus PWWP domain (Pro-Trp-Trp-Pro) [126].”
BackgroundMajumdar, A., Chatterjee, A. G., Ripmaster, T. L., & Levin, H. L. (2011) · Journal of Virology · doi:10.1128/jvi.01719-10 · Cited by 19
Role of host-encoded proteins in restriction of retroviral integration
Suzuki, Y., Chew, M. L., & Suzuki, Y. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00227 · Cited by 33
“This protein was identified as an interaction partner of HIV-1 IN through a co-immunoprecipitation study in human cells (Cherepanov et al., 2003) and has been shown to stimulate in vitro integration activity of IN (Cherepanov et al., 2004).”
BackgroundLi, M., Chen, X., Wang, H., Jurado, K. A., Engelman, A. N., & Craigie, R. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.01.040 · Cited by 18
Self-citationImplications of Fragment-Based Drug Discovery in Tuberculosis and HIV
Mallakuntla, M. K., Togre, N. S., Santos, D. B., & Tiwari, S. (2022) · Pharmaceuticals · doi:10.3390/ph15111415 · Cited by 17
HLA-associated production of anti-DFS70/LEDGF autoantibodies and systemic autoimmune disease
Muro, Y., Ogawa, Y., Sugiura, K., & Tomita, Y. (2006) · Journal of Autoimmunity · doi:10.1016/j.jaut.2006.03.005 · Cited by 18
Zinc Finger Endonuclease Targeting PSIP1 Inhibits HIV-1 Integration
Badía, R., Pauls, E., Riveira‐Muñoz, E., Clotet, B., Esté, J. A., & Ballana, E. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02690-14 · Cited by 22
“All identified missense mutations are located in the helixturn-helix (HTH) motifs at the C-terminal region of the protein, which is after the IBD.”
BackgroundInfluentialDebyser, Z., Bruggemans, A., Belle, S. V., Janssens, J., & Christ, F. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-16-0267-2_4 · Cited by 18
Battista, S., Fedele, M., Secco, L., Ingo, A. M. D., Sgarra, R., & Manfioletti, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168863 · Cited by 20
“In addition, the p75 isoform has an integrase-binding domain (IBD) that tethers HIV-1 enzyme integrase (IN) to host chromosomes, preventing IN degradation [130], and generally plays an important role in tethering protein complexes to chromatin [131].”
BackgroundTakahata, T., Takeda, E., Tobiume, M., Tokunaga, K., Yokoyama, M., Huang, Y.-L., Hasegawa, A., Shioda, T., Sato, H., Kannagi, M., et al. (2016) · Journal of Virology · doi:10.1128/jvi.02003-16 · Cited by 18
“factor, lens epithelium-derived growth factor (LEDGF)/p75 (37).”
Retroviral integrase: Structure, mechanism, and inhibition
Passos, D. O., Li, M., Craigie, R., & Lyumkis, D. (2021) · The Enzymes · doi:10.1016/bs.enz.2021.06.007 · Cited by 22
The C-Terminal Domain of HIV-1 Integrase: A Swiss Army Knife for the Virus?
Rocchi, C., Gouet, P., Parissi, V., & Fiorini, F. (2022) · Viruses · doi:10.3390/v14071397 · Cited by 19
Gu, W.-G., Ip, D. T.-M., Liu, S.-J., Chan, J. H., Wang, Y., Zhang, X., Zheng, Y., & Wan, D. C. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.01.011 · Cited by 18
Targeting Virus-host Interactions of HIV Replication
Weydert, C., Rijck, J. D., Christ, F., & Debyser, Z. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150901115106 · Cited by 17
De novo design of small molecule inhibitors targeting the LEDGF/p75-HIVintegrase interaction
Cavalluzzo, C., Voet, A. R. D., Christ, F., Singh, B. K., Sharma, A. K., Debyser, Z., Maeyer, M. D., & der Eycken, E. V. V. (2011) · RSC Advances · doi:10.1039/c1ra00582k · Cited by 19
Metal-dependent inhibition of HIV-1 integrase by 5CITEP inhibitor: A theoretical QM/MM approach
do Nascimento, J. L. M., Silva, J. R. A., Lameira, J., & Alves, C. N. (2013) · Chemical Physics Letters · doi:10.1016/j.cplett.2013.08.006 · Cited by 16
Burlein, C., Wang, C., Xu, M., Bhatt, T., Stahlhut, M. W., Ou, Y., Adam, G. C., Heath, J., Klein, D. J., Sanders, J. M., et al. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00550 · Cited by 14
Naidu, B. N., Patel, M., McAuliffe, B. V., Ding, B., Cianci, C., Simmermacher, J., Jenkins, S., Parker, D. D., Sivaprakasam, P., Khan, J., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c02169 · Cited by 14
Ishihara, K., Fatma, N., Bhargavan, B., Chhunchha, B., Kubo, E., Dey, S., Takamura, Y., Kumar, A., & Singh, D. P. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08686.x · Cited by 16
LEDGF/p75 TATA-Less Promoter Is Driven by the Transcription Factor Sp1
Desfarges, S., Abderrahmani, A., Hernández‐Novoa, B., Muñoz, M., & Ciuffi, A. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.10.010 · Cited by 14
Lessons Learned: HIV Points the Way Towards Precision Treatment of Mixed-Lineage Leukemia
Čermáková, K., Weydert, C., Christ, F., Rijck, J. D., & Debyser, Z. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.05.005 · Cited by 14
Vets, S., Rijck, J. D., Brendel, C., Grez, M., Bushman, F. D., Debyser, Z., & Gijsbers, R. (2013) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2013.4 · Cited by 13
Singh, P., Li, W., Bedwell, G., Fadel, H., Poeschla, E., & Engelman, A. (2022) · Viruses · doi:10.3390/v14091883 · Cited by 13
Self-citationHendrix, J., van Heertum, B., Vanstreels, E., Daelemans, D., & Rijck, J. D. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.525964 · Cited by 16
“Next to the PWWP domain, LEDGF/p75 contains a conserved integrase-binding domain (IBD) absent in the p52 splice variant (9).”
BackgroundHost Cell Factors and HIV-1 Integration
Engelman, A. (2007) · Future HIV Therapy · doi:10.2217/17469600.1.4.415 · Cited by 14
Self-citationInteractions of Host Proteins with the Murine Leukemia Virus Integrase
Studamire, B., & Goff, S. P. (2010) · Viruses · doi:10.3390/v2051110 · Cited by 14
“However, the murine protein plays no apparent role in MLV integration, suggesting the possibility that different host factors may be required for tethering either the PIC or viral DNA to selected regions of chromatin for this virus [83,84].”
BackgroundBennett, G. R., Peters, R., Wang, X., Hanne, J., Sobol, R. W., Bundschuh, R. A., Fishel, R. A., & Yoder, K. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103164 · Cited by 14
“The host protein LEDGF has been shown to directly bind the HIV integration complex and direct integration to sites within chromatin [46–48].”
1,2,3,4‐Tetrahydroisoquinolines as inhibitors of HIV ‐1 integrase and human LEDGF /p75 interaction
George, A., Reddy, A. G. K., Satyanarayana, G., & Raghavendra, N. K. (2018) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13175 · Cited by 13
Virus–Host Interactions in Retrovirus Integration
Engelman, A. N., & Maertens, G. N. (2018) · Retrovirus-Cell Interactions · doi:10.1016/b978-0-12-811185-7.00004-2 · Cited by 12
Self-citationLopez, A. P., Kugelman, J. R., Garcia-Rivera, J. A., Urias, E., Salinas, S. A., Fernández-Zapico, M. E., & Llano, M. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.05.013 · Cited by 14
Infantino, M. G., Carbone, T., Manfredi, M., Grossi, V., Benucci, M., Casiano, C. A., & Bizzaro, N. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.07.001 · Cited by 12
Targeting Cellular Cofactors in HIV Therapy
Dürr, R., Keppler, O. T., Christ, F., Crespan, E., Garbelli, A., Maga, G., & Dietrich, U. (2014) · Topics in medicinal chemistry · doi:10.1007/7355_2014_45 · Cited by 12
Bradley, C. M., & Craigie, R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509078102 · Cited by 14
Metadata
- Authors
- Cherepanov, P., Devroe, E., Silver, P. A., & Engelman, A.
- Affiliations
- Dana-Farber Cancer Institute (US)
- Harvard University (US)
- Corresponding author
- Engelman, Alan
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-11
- Volume
- 279
- Issue
- 47
- Pages
- 48883-48892
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1964170347
- Cited by
- 287
- References
- 57
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 9 · 2023: 2 · 2022: 16 · 2021: 9 · 2020: 10 · 2019: 5 · 2018: 11 · 2017: 8 · 2016: 7 · 2015: 18 · 2014: 23 · 2013: 20 · 2012: 22
- FWCI
- 4.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5833 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (AI39394)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Keywords
- LEDGF/p75, HIV-1 integrase, PWWP domain, HRP-2, protein domain organization, HIV-1 replication, protein-protein interaction
- MeSH terms
- Amino Acid Sequence, Animals, Cell Line, Cloning, Molecular, DNA, Glutathione, Glutathione Transferase, Humans, Lens, Crystalline, Molecular Sequence Data, Protein Binding, Recombinant Proteins, Mass Spectrometry, Temperature, Transfection, Conserved Sequence, Gene Deletion, Sequence Homology, Amino Acid, Protein Structure, Secondary, Protein Structure, Tertiary, DNA, Complementary, Evolution, Molecular, Computational Biology, HIV Integrase, Intercellular Signaling Peptides and Proteins, Immunoprecipitation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.